Log in to save to my catalogue

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative d...

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative d...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_06fc3859d18c4c1fbaf9c9d009b5284c

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

About this item

Full title

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Publisher

England: BioMed Central Ltd

Journal title

World journal of surgical oncology, 2018-08, Vol.16 (1), p.160-160, Article 160

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Giant cell tumor of bone (GCTB) is an intermediate tumor known to be locally aggressive, but rarely metastasizing. To plan a prospective study of GCTB, we performed a questionnaire survey for institutions participating in the Bone and Soft Tissue Tumor Study Group (BSTTSG) in the Japan Clinical Oncology Group (JCOG) in 2015.
We reviewed 158 cons...

Alternative Titles

Full title

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_06fc3859d18c4c1fbaf9c9d009b5284c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_06fc3859d18c4c1fbaf9c9d009b5284c

Other Identifiers

ISSN

1477-7819

E-ISSN

1477-7819

DOI

10.1186/s12957-018-1459-6

How to access this item